F. Jourdan

发表

Design, Synthesis and Antiviral Activity of New Pyridinone Derivatives

R. Bureau, A. Aubertin, A. Kirn, 1997 .

Potassium Cyanate as an Amino-dehydroxylating Agent: Synthesis of Aminooxypyrrole Mono, Dicarboxylic Acid Esters, and Carbonitrile

D. Lowe, F. Jourdan, J. Kaiser, 2003 .

Purification and characterization of the FeII- and alpha-ketoglutarate-dependent xanthine hydroxylase from Aspergillus nidulans.

Andrew W. Stumpff-Kane, C. Scazzocchio, R. Hausinger, 2007, Biochemistry.

In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer

B. Potter, J. Day, A. Purohit, 2014, British Journal of Cancer.

In vivo and in vitro properties of STX 2484 : a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer

B. Potter, J. Day, A. Purohit, 2014 .

Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors

Mark P Thomas, B. Potter, E. Hamel, 2011, ACS medicinal chemistry letters.

Chimeric microtubule disruptors.

B. Potter, K. Acharya, A. Purohit, 2010, Chemical communications.

Optimisation of Tetrahydroisoquinoline‐Based Chimeric Microtubule Disruptors

B. Potter, E. Hamel, M. Leese, 2014, ChemMedChem.

Synthesis of thieno[3,2-d]pyrimidine-2,4-diones cyclic and acyclic nucleosides as potential anti HIV agents

M. Robba, F. Jourdan, D. Ladurée, 1994 .

Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines

B. Potter, B. Potter, A. Purohit, 2014, ChemMedChem.

Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.

B. Potter, A. Purohit, M. Reed, 2008, Organic & biomolecular chemistry.

o-Bis(allyldimethylsilyl)benzene as a remarkably effective allylation agent for carbonyl compounds with Bu4NF catalyst

K. Maruoka, N. Asao, F. Jourdan, 1998 .

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.

M. Steinmetz, B. Potter, A. Prota, 2018, Journal of medicinal chemistry.

Synthesis of cyclic and acyclic nucleoside analogues having a thiophene or dihydrothiophene ring fused to the d side of an uracil

M. Robba, F. Jourdan, J. Renault, 1995 .

Cover Picture: Tetrahydroisoquinolinone‐Based Steroidomimetic and Chimeric Microtubule Disruptors (ChemMedChem 1/2014)

B. Potter, E. Hamel, M. Leese, 2014 .

A left‐handed α‐helix containing both L‐ and D‐amino acids: The solution structure of the antimicrobial lipodepsipeptide tolaasin

P. Amodeo, A. Motta, A. Evidente, 2003, Proteins.

Synthesis of New N‐(5‐Oxo‐2,5‐dihydro)pyrrol‐3‐yl Glycines and N‐(5‐Oxo‐2,5‐dihydro)pyrrol‐3‐yl Glycines Esters

D. Lowe, F. Jourdan, Jens T. Kaiser, 2005 .

The cytoplasmic tail of invariant chain regulates endosome fusion and morphology.

A. Motta, O. Bakke, J. Gorvel, 2002, Molecular biology of the cell.

Tetrahydroisoquinolinone‐Based Steroidomimetic and Chimeric Microtubule Disruptors

B. Potter, E. Hamel, M. Leese, 2014, ChemMedChem.

Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.

B. Potter, A. Purohit, M. Reed, 2010, Journal of medicinal chemistry.

Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents.

B. Potter, A. Purohit, S. Newman, 2011, Journal of medicinal chemistry.

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.

M. Steinmetz, B. Potter, A. Prota, 2018, Journal of medicinal chemistry.

Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.

B. Potter, A. Purohit, M. Reed, 2008, Organic & biomolecular chemistry.